Filing Details
- Accession Number:
- 0001600132-17-000113
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-10-03 16:07:16
- Reporting Period:
- 2017-09-29
- Accepted Time:
- 2017-10-03 16:07:16
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1600132 | Bellerophon Therapeutics Inc. | BLPH | Pharmaceutical Preparations (2834) | 473116175 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1646754 | Naseem Amin | C/O Bellerophon Therapeutics, Inc. 184 Liberty Corner Road, Suite 302 Warren NJ 07059 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-09-29 | 456,432 | $0.00 | 1,230,314 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Common Stock Warrants (right to buy) | Acquisiton | 2017-09-29 | 456,432 | $0.00 | 456,432 | $1.24 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
456,432 | 2018-03-29 | 2022-09-29 | No | 4 | P | Direct |
Footnotes
- The reported securities are included within Units purchased by the reporting person for $1.205 per Unit. Each Unit consists of one share of common stock and one warrant to purchase one share of common stock.